MedTrace Logo

Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor

NCT01314391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-18

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in blood and tumor tissue samples from patients with Wilms tumor.

Conditions

Interventions

GENETIC

mutation analysis

GENETIC

polymerase chain reaction

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Vicki Huff, PhD · M.D. Anderson Cancer Center

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2016-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01314391 on ClinicalTrials.gov